Dermatologic complications after liver transplantation: a single-center experience

Area of Science:

• Hepatology
• Dermatology
• Transplantation Medicine

Background:

• Liver transplantation (LT) is a life-saving procedure for end-stage liver disease.
• Immunosuppressive therapy is crucial for graft survival post-LT.
• Dermatological complications can impact patient quality of life and graft outcomes.

Purpose of the Study:

• To document the incidence and types of dermatological complications following deceased donor liver transplantation (DDLT) and living-donor liver transplantation (LDLT).
• To identify the relationship between immunosuppressive agents and post-transplant skin conditions.
• To evaluate management strategies for these dermatological issues.

Main Methods:

• A retrospective review of 116 liver transplantation procedures (73 DDLTs, 43 LDLTs) performed between April 2001 and November 2006.
• Documentation of all post-transplant dermatological problems encountered in 112 patients.
• Analysis of the association between complications and immunosuppressive regimens.

Main Results:

• 14 out of 112 (12.5%) liver transplant recipients developed dermatological complications.
• Common issues included drug-induced conditions (e.g., vasculitis, gingival hyperplasia, hypertrichosis), infections (herpes zoster, herpes simplex), and pressure-related issues.
• Over half (57%) of the dermatological complications were attributed to immunosuppressive drugs.

Conclusions:

• Dermatological complications are a frequent occurrence after liver transplantation.
• Immunosuppressive therapy is a primary driver of these post-transplant skin conditions.
• Optimizing immunosuppression is key to preventing and managing most dermatological issues, often with simple adjustments.